Item type |
itemtype_ver1(1) |
公開日 |
2021-12-03 |
タイトル |
|
|
タイトル |
Prevalence of acute coronary syndrome during the pandemic of COVID-19 in the Tokai Region of Japan |
|
言語 |
en |
著者 |
Kudo, Nobutaka
Tanaka, Akihito
Ishii, Hideki
Uemura, Yusuke
Takagi, Kensuke
Iwama, Makoto
Yoshida, Ruka
Ohashi, Taiki
Kawai, Hideki
Negishi, Yosuke
Umemoto, Norio
Tanaka, Miho
Watarai, Masato
Yoshioka, Naoki
Morishima, Itsuro
Noda, Toshiyuki
Yoshida, Yukihiko
Tatami, Yosuke
Muramatsu, Takashi
Tanaka, Toshikazu
Tashiro, Hiroshi
Takada, Yasunobu
Izawa, Hideo
Watanabe, Eiichi
Murohara, Toyoaki
|
アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
権利 |
|
|
言語 |
en |
|
権利情報Resource |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
|
権利情報 |
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International |
キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
COVID-19 |
キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
acute coronary syndrome |
内容記述 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
The outbreak of coronavirus disease 19 (COVID-19) has had a great impact on medical care. During the COVID-19 pandemic, the rate of hospital admissions has been lower and the rate of in-hospital mortality has been higher in patients with acute coronary syndrome (ACS) in Western countries. However, in Japan, it is unknown whether the COVID-19 pandemic has affected the incidence of ACS. In the study, eleven hospitals in the Tokai region participated. Among enrolled hospital, we compared the incidence of ACS during the COVID-19 pandemic (April and May, 2020) with that in equivalent months in the preceding year as the control. During the study period; April and May 2020, 248 patients with ACS were admitted. Compared to April and May 2019, a decline of 8.1% [95% confidence interval (CI) 5.2–12.1; P = 0.33] in admissions for ACS was observed between April and May 2020. There was no significant difference in the strategy for revascularization and in-hospital deaths between 2019 and 2020. In conclusion, the rate of admission for ACS slightly decreased during the COVID-19 pandemic, compared to the same months in the preceding year. Moreover, degeneration of therapeutic procedures for ACS did not occur. |
|
言語 |
en |
出版者 |
|
|
出版者 |
Nagoya University Graduate School of Medicine, School of Medicine |
|
言語 |
en |
言語 |
|
|
言語 |
eng |
資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
departmental bulletin paper |
出版タイプ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
ID登録 |
|
|
ID登録 |
10.18999/nagjms.83.4.697 |
|
ID登録タイプ |
JaLC |
関連情報 |
|
|
関連タイプ |
isVersionOf |
|
|
識別子タイプ |
URI |
|
|
関連識別子 |
https://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/834.html |
収録物識別子 |
|
|
収録物識別子タイプ |
PISSN |
|
収録物識別子 |
0027-7622 |
収録物識別子 |
|
|
収録物識別子タイプ |
EISSN |
|
収録物識別子 |
2186-3326 |
書誌情報 |
en : Nagoya Journal of Medical Science
巻 83,
号 4,
p. 697-703,
発行日 2021-11
|